Anticonvulsant pharmaceutical composition for transnasal administration, comprising: - a poorly soluble anticonvulsant as active component; - diethylene glycol monoethyl ether; and - fatty acid ester selected from the group consisting of caprilocaproyl polyoxyl glyceride, isopropyl palmitate, oeloyl polyoxyl glyceride, sorbitan monolaurate 20, methyl laurate, ethyl laurate, and polysorbate 20.
展开▼